Genmab A/S Dkk

(GNMSF)

By |

Profile

Genmab A/S is an antibody company focused on cancer. Its first marketed product is Arzerra (ofatumumab); development pipeline incl. daratumumab and two proprietary technology platforms; DuoBody (bispecifics) & HexaBody (effector function enhancement).

Contact Information

Website: www.genmab.com
Main Phone: +45 70202728
Address: Bredgade 34E
City / Town: Copenhagen K
Country: DNK
Postal Code: 1260

Issuer Information

Exchange: GREY
Employees: 189
$ 190.75 $ 2.75 (1.46%)
Last Price 190.75 Change $ 2.75 Change % 1.46 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 190.75 High 190.75 Low 190.75 Prev Close 188.00
Last Trade Volume 5,622 52 Wk Hi 239.75 52 Wk Low 163.00
Market Cap 11.7 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 61,085,674.00 EPS (TTM) 2.66 PE Ratio 71.70 Exchange OTCPK
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 51.98 51.98 51.98 13.68
Low Target Price Estimate 51.98 51.98 51.98 13.68
Mean Target Price Estimate 51.98 51.98 51.98 13.68
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 08/23/07 08/23/07 08/23/07 04/28/10
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1